Department of Surgery, Division of Neurosurgery, Centre Hospitalier de l'Université de Montréal (CHUM), Hôpital Notre-Dame, 1560 rue Sherbrooke Est, Montreal, Quebec, H2L 4M1, Canada.
Acta Neurochir (Wien). 2012 Oct;154(10):1845-50. doi: 10.1007/s00701-012-1461-7. Epub 2012 Aug 12.
Endoscopic third ventriculostomy (ETV) is an effective treatment of obstructive hydrocephalus (OH). However, the presence of a large or giant basilar aneurysm is generally considered a contra-indication to ETV for treating hydrocephalus. We report the feasibility and efficacy of ETV for the treatment of hydrocephalus in the presence of such aneurysms.
We performed a retrospective chart analysis of patients that underwent ETV for large or giant basilar aneurysm-associated hydrocephalus between January 2003 and January 2011.
During this period, 78 patients were treated by ETV. Of these, three patients presented with symptomatic hydrocephalus associated with a large giant basilar aneurysm (n = 3). Two of those patients had a history of previous subarachnoid hemorrhage (SAH) with intraventricular hemorrhage (IVH) 11 years and 13 years before ETV. Both aneurysms were embolized preoperatively. The third patient presented with OH due to an unruptured basilar artery aneurysm. There was no operative complication and symptoms resolution was observed in all patients at last follow-up.
ETV is a safe and effective alternative to ventriculo-peritoneal shunting in patients with hydrocephalus caused by large or giant basilar artery aneurysms. In addition, a history of SAH/IVH should not be considered a contra-indication to ETV.
内镜第三脑室造瘘术(ETV)是治疗梗阻性脑积水(OH)的有效方法。然而,存在大型或巨大基底动脉瘤通常被认为是 ETV 治疗脑积水的禁忌症。我们报告了在存在此类动脉瘤的情况下,通过 ETV 治疗脑积水的可行性和疗效。
我们对 2003 年 1 月至 2011 年 1 月期间因大型或巨大基底动脉瘤相关脑积水而行 ETV 的患者进行了回顾性图表分析。
在此期间,78 例患者接受了 ETV 治疗。其中,3 例患者出现与大型/巨大基底动脉瘤相关的症状性脑积水(n = 3)。其中 2 例患者有蛛网膜下腔出血(SAH)和脑室出血(IVH)病史,分别为 11 年前和 13 年前,均在术前进行了动脉瘤栓塞。第 3 例患者因未破裂的基底动脉动脉瘤而出现 OH。所有患者均无手术并发症,在最后一次随访时症状均得到缓解。
对于由大型或巨大基底动脉瘤引起的脑积水患者,ETV 是一种安全有效的替代脑室-腹腔分流术的方法。此外,SAH/IVH 病史不应被视为 ETV 的禁忌症。